WHO ICTRP trial
Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral…
EUCTR2004-000441-38-IE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-000441-38-IE |
|---|---|
| Public title | Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) - SMART |
| Scientific title | Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) - SMART |
| Primary sponsor | National Institute of Allergy and Infectious Diseases, National Institutes of Health |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Ireland;Austria;Italy |
| Conditions | HIV infection MedDRA version: 8.1 Level: LLT Classification code 10020161 Term: HIV infection |
| Interventions | Pharmaceutical Form: Tablet INN or Proposed INN: ZIDOVUDINE CAS Number: 30516-87-1 Current Sponsor code: ZDV Other descriptive name: Retrovir Concentration unit: mg/g milligram(s)/gram Concentration type: range Concentration number: 100-300 |
| Registration date | Nov 24, 2006 |
| Target size | 6000 |
| Secondary IDs | CPCRA 065;2004-000441-38-AT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: